A novel technique for treating GBM first underwent a phase 1 clinical trial with patients who had recurrence of their cancers ...

A new CAR-T cell therapy has shown promising early results against glioblastoma, a highly aggressive brain cancer. In a phase ...

Preclinical data demonstrates leronlimab-mediated CCR5 inhibition enhances Temozolomide and radiation response in Glioblastoma Leronlimab ...

Half of patients with GBM present with headaches at diagnosis, which is attributed to increases in intracranial pressure (Table 2). 11 Papilledema, now rarely seen because imaging is typically ...

REDMOND, Wash., March 16, 2026 (GLOBE NEWSWIRE)-- Pattern Computer®, Inc. (“Pattern” or “the Company”), the global leader in Pattern Discovery, today announced that the Company has discovered a new ...

The most common and aggressive type of adult brain cancer, glioblastoma multiforme (GBM) is notoriously resistant to treatment, with a median survival of just 14 months following diagnosis. Its ...

Researchers have secured two key grants to investigate targeting a gene for the first time as a new approach to treat glioblastoma, a very aggressive and fast-growing type of brain cancer. Florida ...

Glioblastoma multiforme cells, illustration. Glioblastoma multiforme is a malignant tumor that arises from astrocytes, one of the support cells of the brain. It is an aggressive cancer with a poor ...

In April 2022, my mother-in-law, Karla, went for a routine physical therapy visit for carpal tunnel pain. The clinic was full and nearly turned her away. Only after she insisted that something felt ...